Clinical trial reports on the evaluation of patient-initiated follow-up in head and neck cancer, highlighting potential adaptation across broader cancer pathways.
A trial is underway to assess the effectiveness and cost-effectiveness of the intervention. If successful, this intervention could be adapted for patients with other cancers or diseases, which is important given the recent shift towards PIFU pathways.
No takes yet. Share an insight, caveat, or question.
Matheson et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: